Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature

Saved in:
Bibliographic Details
Main Authors: Patricia Lopez, Sven Kohler, Seema Dimri
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2014/305931
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566648396054528
author Patricia Lopez
Sven Kohler
Seema Dimri
author_facet Patricia Lopez
Sven Kohler
Seema Dimri
author_sort Patricia Lopez
collection DOAJ
format Article
id doaj-art-e1e6f3a1ad9c4400a7cb1c1acbe47453
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-e1e6f3a1ad9c4400a7cb1c1acbe474532025-02-03T01:03:42ZengWileyJournal of Transplantation2090-00072090-00152014-01-01201410.1155/2014/305931305931Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the LiteraturePatricia Lopez0Sven Kohler1Seema Dimri2Novartis Pharma AG, Postfach, 4002 Basel, SwitzerlandNovartis Pharma AG, Postfach, 4002 Basel, SwitzerlandNovartis Healthcare Pvt. Ltd., Raheja Mindspace, Hitech City, Madhapur, Hyderabad, Rangareddy 500081, Indiahttp://dx.doi.org/10.1155/2014/305931
spellingShingle Patricia Lopez
Sven Kohler
Seema Dimri
Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
Journal of Transplantation
title Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
title_full Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
title_fullStr Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
title_full_unstemmed Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
title_short Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
title_sort interstitial lung disease associated with mtor inhibitors in solid organ transplant recipients results from a large phase iii clinical trial program of everolimus and review of the literature
url http://dx.doi.org/10.1155/2014/305931
work_keys_str_mv AT patricialopez interstitiallungdiseaseassociatedwithmtorinhibitorsinsolidorgantransplantrecipientsresultsfromalargephaseiiiclinicaltrialprogramofeverolimusandreviewoftheliterature
AT svenkohler interstitiallungdiseaseassociatedwithmtorinhibitorsinsolidorgantransplantrecipientsresultsfromalargephaseiiiclinicaltrialprogramofeverolimusandreviewoftheliterature
AT seemadimri interstitiallungdiseaseassociatedwithmtorinhibitorsinsolidorgantransplantrecipientsresultsfromalargephaseiiiclinicaltrialprogramofeverolimusandreviewoftheliterature